Market Overview A recent report by Reports and Data projects a 9.2% growth rate in the global Liquid Embolic market, reaching USD 3.27 Billion by 2027 from 2019. Liquid embolic agents play a crucial role in preventing blood supply to aneurysms or tumors, effectively curbing their growth and mitigating adverse effects on vital organs.

The global growth of the transcatheter embolization market is evident, serving diverse medical fields such as peripheral vascular disease (PVD), oncology, urology, and neurology. Although the cost-effective nature of clipping and coiling has traditionally been a dominant approach, these methods encounter limitations and complications.

Get a sample copy of the Liquid Embolic Market report: https://www.reportsanddata.com/download-free-sample/2690

Commercially available liquid embolic agents have proven successful in treating conditions like varicoceles, peripheral vascular lesions, and hypervascular tumors. The market's expansion is influenced by the rising incidence of neurovascular diseases, particularly among individuals above 65 years, who are more susceptible to vascular issues.

Anticipated growth in the liquid embolic market is attributed to the development of next-generation agents, addressing current product limitations. The increasing demand for embolization therapies presents opportunities for introducing solutions that offer better clinical outcomes compared to existing transcatheter embolization devices.

Report Highlights

• Region and country-wise statistics from 2016-2027, with 2018 as the base year and 2019-2027 as forecasts.
• Market size estimation, historical and forecasted trend analysis.
• Analysis of available technologies and their individual market shares.
• Estimation of application shares, including Brain Arteriovenous Malformations, Tumor and Brain Cancer, Brain Aneurysm, and Ischemic Stroke.
• Regional outlook on upcoming research, application trends, prevalence mapping, and competitive pricing strategies.

Key Market Trends

• Liquid embolic administration through DMSO-compatible micro-catheters for precise navigation.
• Applications for treating spider veins, cerebral AVMs, hemorrhoids, varicose veins, and hydroceles.
• North America leading in market share due to advanced equipment availability and rapid adoption of innovative surgeries, driven by a growing geriatric population.
• Sales growth expected, supported by clinical trials favoring conservative management over embolization for brain AVMs.
• Government initiatives boosting healthcare infrastructure in the Asia Pacific, attracting global companies.

Companies Profiled Medtronic, Cyberonics, InoMed, Boston Scientific, Codman and Shurtleff, RauMedic, St. Jude Medical, Stryker, Mizuho America, Integra LifeSciences, among others.

Market Insights

• The Liquid Embolic market valuation was USD 1.47 Billion in 2018, projected to reach USD 3.27 Billion by 2027.
• Liquid embolic's advantages over coil limitations, coupled with increasing clinical trials and endorsements, are expected to drive market demand.
• The U.S. dominates the market, with significant sales related to neurovascular indications and notable off-label usage.
• Ambulatory surgical centers' rise, focusing on minimally invasive surgeries, propels the Liquid Embolic Market.
• Europe expected to hold a significant market share due to major players and government investments in healthcare.

Segments Covered

• Product: Isobutyl-2-Cyanoacrylate (IBCA), Sodium Morrhuate, Ethanol, Bletilla Striata.
• Application: Brain Arteriovenous Malformations, Tumor and Brain Cancer, Brain Aneurysm, Ischemic Stroke.
• End Users: Hospitals, Ambulatory Surgical Centers.
• Region: North America, Europe, Asia Pacific, MEA, Latin America.

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/2690

Thank you for taking the time to read our article. The report can be tailored to the needs of the client. Please contact us for more details, and our team will tailor the report to your specific requirements.

Explore Trending Reports:

3D Printing Packaging Market -https://bhagyashrishewale.blogspot.com/2023/07/3d-printing-packaging-market-size.html

LTCC & HTCC Market-https://bhagyashrishewale.blogspot.com/2023/08/ltcc-htcc-market-to-exceed-valuation-of.html

Perovskite Solar Cells Market-https://bhagyashrishewale.blogspot.com/2023/08/perovskite-solar-cells-market-is.html

Industrial Boiler Market-https://bhagyashrishewale.blogspot.com/2023/08/industrial-boiler-market-is-expected-to.html

About Reports and Data                                   

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report

Browse Latest Blogs: https://www.reportsanddata.com/blogs

Browse Latest Press Release: https://www.reportsanddata.com/press-release